Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA IS REPORTEDLY EXPECTED TO LIFT RESTRICTION ON PEPTIDES NYT A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are Dihexa Peptide Therapy Memory & Cognition Beverly Hills